7th annual Advances in Cell Based Assays Conference

Clinical failure in the pharmaceutical industry remains at a phenomenal 90%. Failed drugs are costly both financially and in terms of human suffering. As a result there is an urgent need in pharmaceutical and academic research for efficient and innovative processes enabling more relevant, predictive and functional cell-based assays in the drug discovery process.